Terms: = Head and neck cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
4692 results:
1. LymphoDose: a lymphocyte dose estimation framework-application to brain radiotherapy.
de Kermenguy F; Benzazon N; Maury P; Vauclin R; M'hamdi M; Cifliku V; Limkin E; Diallo I; Morel D; Milewski C; Clémenson C; Mondini M; Deutsch E; Robert C
Phys Med Biol; 2024 Apr; 69(10):. PubMed ID: 38593817
[No Abstract] [Full Text] [Related]
2. Multiple pathological fractures and muscle atrophy caused by a parathyroid carcinoma with postoperative hungry bone syndrome: A case report.
Liu Q; Zhang Y; Ma D; Gengzhi H; Maimaiti Y; Chen Q; Ma Z
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2047. PubMed ID: 38577726
[TBL] [Abstract] [Full Text] [Related]
3. Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells.
Salama M; Ali A; Ibrahim FAR; Elabd S
Med Oncol; 2024 Apr; 41(5):105. PubMed ID: 38573558
[TBL] [Abstract] [Full Text] [Related]
4. Malnutrition in head and neck Free Flap Reconstruction as a Predictor of Adverse Outcomes.
Herzog I; Panchal D; Sikder S; Park JB; Mendiratta D; Mansukhani PA; Lee ES
Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S251-S254. PubMed ID: 38556683
[TBL] [Abstract] [Full Text] [Related]
5. Biodosimetric analysis of head and neck cancer patients undergoing radiotherapy by dicentric chromosome aberration assay.
Agarwal N; Rathi AK; Kapoor S; Singh K; Arora S; Jindal A; Prabhat K; Kaushik H
J Cancer Res Ther; 2024 Jan; 20(1):321-326. PubMed ID: 38554341
[TBL] [Abstract] [Full Text] [Related]
6.
Cytryn SL; Pandit-Taskar N; Lumish MA; Maron SB; Gu P; Ku GY; Chou JF; Capanu M; Antoine A; Loegel D; Feder L; Philemond S; Lyashchenko SK; Lewis JS; Paroder V; Srivastava A; Tang LH; Schoder H; Janjigian YY
J Nucl Med; 2024 May; 65(5):722-727. PubMed ID: 38514081
[TBL] [Abstract] [Full Text] [Related]
7. Advances in testing for human papillomavirus -mediated head and neck cancer.
Mehanna H; Alemany L; von Buchwald C
Curr Opin Oncol; 2024 May; 36(3):143-146. PubMed ID: 38506408
[TBL] [Abstract] [Full Text] [Related]
8. Cholesterol depletion induces mesenchymal properties in oral squamous cell carcinoma cell line.
do Nascimento RB; Cerqueira PSG; Silva JC; Fontes EK; Dos Santos EA; Dos Santos JN; Nunes FD; Rodrigues MFSD; Paiva KBS; Xavier FCA
J Oral Pathol Med; 2024 Apr; 53(4):246-257. PubMed ID: 38503722
[TBL] [Abstract] [Full Text] [Related]
9. Unraveling the Genetic Web: H-Ras Expression and Mutation in Oral Squamous Cell Carcinoma-A Systematic Review.
Devi P; Dwivedi R; Sankar R; Jain A; Gupta S; Gupta S
Head Neck Pathol; 2024 Mar; 18(1):21. PubMed ID: 38502412
[TBL] [Abstract] [Full Text] [Related]
10. Functional Laryngectomy and Quality of Life in Survivors of head and neck cancer With Intractable Aspiration.
Evangelista L; Nativ-Zeltzer N; Bewley A; Birkeland AC; Abouyared M; Kuhn M; Cates DJ; Farwell DG; Belafsky P
JAMA Otolaryngol Head Neck Surg; 2024 Apr; 150(4):335-341. PubMed ID: 38451502
[TBL] [Abstract] [Full Text] [Related]
11. FD-Net: Feature Distillation Network for Oral Squamous Cell Carcinoma Lymph Node Segmentation in Hyperspectral Imagery.
Zhang X; Li Q; Li W; Guo Y; Zhang J; Guo C; Chang K; Lovell NH
IEEE J Biomed Health Inform; 2024 Mar; 28(3):1552-1563. PubMed ID: 38446656
[TBL] [Abstract] [Full Text] [Related]
12. Beta-defensin index: A functional biomarker for oral cancer detection.
Ghosh SK; Man Y; Fraiwan A; Waters C; McKenzie C; Lu C; Pfau D; Kawsar H; Bhaskaran N; Pandiyan P; Jin G; Briggs F; Zender CC; Rezaee R; Panagakos F; Thuener JE; Wasman J; Tang A; Qari H; Wise-Draper T; McCormick TS; Madabhushi A; Gurkan UA; Weinberg A
Cell Rep Med; 2024 Mar; 5(3):101447. PubMed ID: 38442713
[TBL] [Abstract] [Full Text] [Related]
13. [Analysis of the outcome of 12 cases of facial nerve tumors].
Shao Z; Zhou M; Yang J; Wang K
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Mar; 38(3):225-229. PubMed ID: 38433692
[No Abstract] [Full Text] [Related]
14. Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Guigay J; Ortholan C; Vansteene D; Cupissol D; Even C; Kaminsky MC; Sire C; Blot E; Debourdeau P; Bozec L; Saada-Bouzid E; Fayette J; Dalloz P; Pointreau Y; Caer HL; Falandry C; Digue L; Braccini A; Lopez S; Guillet P; Michel C; Cheurfa N; Schwob D; Bourhis J; Mertens C; Aupérin A;
Lancet Healthy Longev; 2024 Mar; 5(3):e182-e193. PubMed ID: 38432247
[TBL] [Abstract] [Full Text] [Related]
15. Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data.
Lippenszky L; Mittendorf KF; Kiss Z; LeNoue-Newton ML; Napan-Molina P; Rahman P; Ye C; Laczi B; Csernai E; Jain NM; Holt ME; Maxwell CN; Ball M; Ma Y; Mitchell MB; Johnson DB; Smith DS; Park BH; Micheel CM; Fabbri D; Wolber J; Osterman TJ
JCO Clin Cancer Inform; 2024 Feb; 8():e2300207. PubMed ID: 38427922
[TBL] [Abstract] [Full Text] [Related]
16. Adenoid cystic carcinoma of the parotid and submandibular glands in children and young adults: A population-based study.
Phillips AL; Li C; Liang J; Sheyn A; Rastatter JC; Chelius DC; Orbach D; Richard C
Pediatr Blood Cancer; 2024 May; 71(5):e30928. PubMed ID: 38418934
[TBL] [Abstract] [Full Text] [Related]
17. From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer.
Li B; Qin W; Yang L; Li H; Jiang C; Yao Y; Cheng S; Zou B; Fan B; Dong T; Wang L
J Transl Med; 2024 Feb; 22(1):195. PubMed ID: 38388379
[TBL] [Abstract] [Full Text] [Related]
18. Rehabilitation Interventions in head and neck cancer: A Scoping Review.
Cheng JT; Ramos Emos M; Leite V; Capozzi L; Woodrow LE; Gutierrez C; Ngo-Huang A; Krause KJ; Parke SC; Langelier DM
Am J Phys Med Rehabil; 2024 Mar; 103(3S Suppl 1):S62-S71. PubMed ID: 38364033
[TBL] [Abstract] [Full Text] [Related]
19. Revisiting Feeding Tube Utilization in Oropharynx cancer: 6-Year Prospective Registry Analysis.
Anderson BJ; Moreno AC; Qing Y; Lee JJ; Johnson FM; Lango MN; Barbon CEA; Tripuraneni L; Sahli A; Piper V; Gross N; Fuller CD; Lai SY; Myers JN; Hutcheson KA
Otolaryngol Head Neck Surg; 2024 May; 170(5):1319-1330. PubMed ID: 38353360
[TBL] [Abstract] [Full Text] [Related]
20. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Besse B; Pons-Tostivint E; Park K; Hartl S; Forde PM; Hochmair MJ; Awad MM; Thomas M; Goss G; Wheatley-Price P; Shepherd FA; Florescu M; Cheema P; Chu QSC; Kim SW; Morgensztern D; Johnson ML; Cousin S; Kim DW; Moskovitz MT; Vicente D; Aronson B; Hobson R; Ambrose HJ; Khosla S; Reddy A; Russell DL; Keddar MR; Conway JP; Barrett JC; Dean E; Kumar R; Dressman M; Jewsbury PJ; Iyer S; Barry ST; Cosaert J; Heymach JV
Nat Med; 2024 Mar; 30(3):716-729. PubMed ID: 38351187
[TBL] [Abstract] [Full Text] [Related]
[Next]
